Nearly one million people in the U.S. and more than six million people worldwide have Parkinson's disease (PD), a debilitating neurological condition characterized by progressive motor and non-motor ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

Morgan Stanley analyst Thibault Boutherin resumed coverage of Grifols (GRFS) with an Overweight rating and EUR 12 price target The company’s ...

GRIFOLS transfer bags are used for sterile preservation and administration of blood components. Blood components can be obtained, stored and preserved without contact with the environment ensuring ...

Learn more about whether Alkermes plc or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Exact Sciences Corporation or Grifols, S.A. is a better investment based on AAII's A+ Investor ...

In a report released yesterday, Tom Jones from Berenberg Bank maintained a Buy rating on Grifols (0RDU – Research Report), with a price target ...

Partnership aims to create recombinant nanobodies to treat immune disorders Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration ...

What Are the BATMMAAN Stocks? If you're ready to move beyond Magnificent Seven stocks, there's a new acronym on Wall Street with one key addition.

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...